News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Iván R. González: 3rd edition of the Advanced Specialty Course in Molecular Oncology
Iván R. González/X
Dec 3, 2024, 17:15

Iván R. González: 3rd edition of the Advanced Specialty Course in Molecular Oncology

Iván R. González, Medical Oncologist at the Comprehensive Cancer Center, Hospital Ángeles Puebla, reshared a post on X by Depor Puebla RHE adding:

“It is an honor to invite you to join the 3rd edition of the Advanced Specialty Course in Molecular Oncology a unique program in Mexico with the potential to transform oncological care in Latin America.

Endorsed by the Centro Oncológico Integral at Hospital Ángeles Puebla and the Universidad de las Américas Puebla, this course is designed for medical oncologists dedicated to advancing cancer treatment.

We look forward to welcoming you.”

Quoting Depor Puebla RHE’s post:

“Call for application open for the 3rd High Specialty course in molecular oncology.”

Read more.

More posts featuring Iván R. González.

Advanced Specialty Course cancer cancer treatment Centro Oncológico Integral comprehensive cancer center Depor Puebla RHE Hospital Ángeles Puebla Latin America medical oncologists Mexico molecular oncology OncoDaily Oncology Universidad de las Américas Puebla
Special Coverage
Blog
Dec 3, 2024, 17:15
Iván R. González: 3rd edition of the Advanced Specialty Course in Molecular Oncology
Blog
Dec 3, 2024, 17:11
Riccardo Campi: Grateful for the Invitation to join the PTU Section of Urologic Oncology
Insight
Dec 3, 2024, 17:10
Sharon Kapambwe: Cervical cancer and HIV are diseases of gender inequality
Insight
Dec 3, 2024, 17:07
The Efficacy and Safety of Mirvetuximab Soravtansine in Recurrent Platinum-Sensitive Ovarian Cancer - Annals of Oncology
Blog
Dec 3, 2024, 17:06
Lacy Hubbard: Discussing the Nation’s Bold Mission 2027—The Goal to Eliminate Cervical Cancer by 2027
Blog
Dec 3, 2024, 17:01
Jeliazko Arabadjiev: Current Systemic Options for HER2-positive Breast Cancer
Insight
Dec 3, 2024, 16:44
5-year results of the OPERA trial - Organ Preservation in Early cT2–cT3 Rectal Adenocarcinoma
Blog
Dec 3, 2024, 16:31
Abstracts are now being accepted for the upcoming IPSON conference - IPOS
Insight
Dec 3, 2024, 16:22
Norbert Galldiks: Identifying Metabolic Responders to Vorasidenib in IDH-Mutant Gliomas
Opinion
Dec 3, 2024, 16:21
Have faith in yourself, and look out for the bad man - reflections from Neil Ranasinghe's involvement in LGCW
Blog
Dec 3, 2024, 16:17
Emad Shash: Uniting for a better patient journey in Breast Cancer Care
OncoDaily Pulse
Dec 3, 2024, 16:10
Join OncoDaily Now: Apply as a Volunteer